深度学习重建超低剂量肝脏多期CT:慢性肝病动脉期非劣效性研究
结果显示超低剂量组动脉期整体图像质量非劣效(差值-0.269,95%CI -0.374至-0.164),动脉期强化病灶对比噪声比显著更优(p<0.05),病灶检出能力非劣效(差值-0.023,95%CI -0.016至0.063)。
要点
- 超低剂量(33.3%剂量)深度学习重建在动脉期图像质量和肝局灶性病变检出上非劣效于标准剂量。
- 动脉期强化病灶对比噪声比在超低剂量组显著更优,有利于病灶显示。
- 慢性肝病患者肝脏多期CT可采用超低剂量方案,辐射剂量降低约66.7%。
局限性
- 仅评估动脉期图像质量和病灶检出,未涉及其他期相。
- 使用特定厂商无关的深度学习模型,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study determined whether image quality and detectability of ultralow-dose hepatic multiphase CT (ULDCT, 33.3% dose) using a vendor-agnostic deep learning model(DLM) are noninferior to those of standard-dose CT (SDCT, 100% dose) using model-based iterative reconstruction(MBIR) in patients with chronic liver disease focusing on arterial phase.
METHODS: Sixty-seven patients underwent hepatic multiphase CT using a dual-source scanner to obtain two different radiation dose CT scans (100%, SDCT and 33.3%, ULDCT). ULDCT using DLM and SDCT using MBIR were compared. A margin of -0.5 for the difference between the two protocols was pre-defined as noninferiority of the overall image quality of the arterial phase image. Quantitative image analysis (signal to noise ratio[SNR] and contrast to noise ratio[CNR]) was also conducted. The detectability of hepatic arterial focal lesions was compared using the Jackknife free-response receiver operating characteristic analysis. Non-inferiority was satisfied if the margin of the lower limit of 95%CI of the difference in figure-of-merit was less than -0.1.
RESULTS: Mean overall arterial phase image quality scores with ULDCT using DLM and SDCT using MBIR were 4.35 ± 0.57 and 4.08 ± 0.58, showing noninferiority (difference: -0.269; 95 %CI, -0.374 to -0.164). ULDCT using DLM showed a significantly superior contrast-to-noise ratio of arterial enhancing lesion (p < 0.05). Figure-of-merit for detectability of arterial hepatic focal lesion was 0.986 for ULDCT using DLM and 0.963 for SDCT using MBIR, showing noninferiority (difference: -0.023, 95 %CI: -0.016 to 0.063).
CONCLUSION: ULDCT using DLM with 66.7% dose reduction showed non-inferior overall image quality and detectability of arterial focal hepatic lesion compared to SDCT using MBIR.
引用
- Lee, Kim, Lee, et al. Ultra-low-dose hepatic multiphase CT using deep learning-based image reconstruction algorithm focused on arterial phase in chronic liver disease: A non-inferiority study. Eur J Radiol. 2022. PMID: 36584563. doi:10.1016/j.ejrad.2022.110659
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。